Bellevue Group’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Bellevue Group’s Portfolio PNT Stock Details PNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,351,160	Closed	-$15.7M	–	178
2023 Q3	$15.7M	Buy	2,351,160 +1,094,963	+87%	+$9.1M	0.25%	78
2023 Q2	$11.4M	Buy	+1,256,197	New	+$11.1M	0.16%	92

Other funds holding PNT

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Bellevue Group's PNT Position: Q4 2023 in Review

Bellevue Group sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 2,351,160 shares — an estimated $15.7M sold.

Bellevue Group first reported a position in PNT in Q2 2023 and held it in 2 quarters. The position peaked at $15.7M in Q3 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

Bellevue Group reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Bellevue Group sold 2,351,160 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $15.7M.
Bellevue Group first reported a position in POINT Biopharma Global Inc. Common Stock in Q2 2023 and held it in 2 quarters.
Bellevue Group's POINT Biopharma Global Inc. Common Stock position peaked at $15.7M in Q3 2023.
1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Bellevue Group's 13F filing for Q4 2023, filed 14 Feb 2024.